The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes
Authors:
- 24 April 2017
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 60 (7) , 1185-1189
Abstract
The role of B lymphocytes in the pathogenesis of type 1 diabetes in humans is not entirely evident. These cells are presumed to be important, but this assumption is largely based on animal models of autoimmune diabetes, where compelling evidence for the contribution of both B lymphocytes and insulin-specific autoantibodies to this disease is in place. For humans, this is much less the case; the exact way in which B lymphocytes and/or autoantibodies may contribute to type 1 diabetes is not yet known but the possibilities include a pathogenic function (‘fire’), or they may represent a surrogate of loss of immune tolerance to beta cells (‘smoke’) or, indeed, they could be a marker of an attempt at immune regulation (‘ice water’). In this issue of Diabetologia, a study by Willcox et al (DOI: 10.1007/s00125-017-4221-7 ) adds new information but no greater clarity on the relevance of B lymphocytes in type 1 diabetes, showing a decrease in germinal centre frequencies in donors with recent-onset type 1 diabetes compared with control donors and donors with longstanding type 1 diabetes. These new findings may guide the research community to design experiments to unambiguously define whether B lymphocytes or their products function as fire, smoke or perhaps ice water in the immunopathogenesis of type 1 diabetes.Keywords
This publication has 37 references indexed in Scilit:
- B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year ResultsDiabetes Care, 2014
- Antigen Targets of Type 1 Diabetes AutoimmunityCold Spring Harbor Perspectives in Medicine, 2012
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patientsJournal of Experimental Medicine, 2012
- Increased T Cell Proliferative Responses to Islet Antigens Identify Clinical Responders to Anti-CD20 Monoclonal Antibody (Rituximab) Therapy in Type 1 DiabetesThe Journal of Immunology, 2011
- Prevention of type 1 diabetes mellitus using a novel vaccineTherapeutic Advances in Endocrinology and Metabolism, 2010
- Autoantibodies and associated T-cell responses to determinants within the 831–860 region of the autoantigen IA-2 in Type 1 diabetesJournal of Autoimmunity, 2009
- Analysis of islet inflammation in human type 1 diabetesClinical and Experimental Immunology, 2008
- CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeJournal of Clinical Investigation, 2008
- The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetesProceedings of the National Academy of Sciences, 2008
- Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4Journal of Clinical Investigation, 1999